HCA Healthcare Inc.'s (NYSE:HCA) stock is trading lower on Tuesday after cutting its fiscal 2026 earnings guidance from $29.10-$31.50 to $28.70-$30.50.
The company also narrowed its 2026 sales guidance from $76.5 billion-$80 billion to $77 billion-$79.5 billion, versus the consensus of $78.643 billion.
After the update, the stock fell around 10% during the premarket session.
The hospital operator reported preliminary second-quarter revenue of approximately $20.23 billion, up from $18.61 billion in the same period last year, compared to the consensus of $19.39 billion.
Net income is projected to reach about $1.70 billion, or $7.62 per diluted share, compared with $1.65 billion, or $6.83 per diluted share, a year earlier.
